Research Study

Past Study: Beta Cell T2D

Study Status: CLOSED

Study Name: Beta Cell T2D

Study Focus: Type 2 Diabetes

 

Study Purpose: The purpose of this study is to better understand how cells that make insulin, known as beta cells, change in response to certain type 2 diabetes medications. Results from this study will help develop therapies to improve beta cell function.    

Study Commitment: The study consists of a total of 4 visits to the TRI-MD facility. The visits include:

  • 1 Screening visit
  • 3 Study visits

Study Duration: up to 10 weeks

Study Qualification: To be enrolled in this study, you must meet certain requirements. You are eligible to participate in one of the following groups if you meet the associated criteria:

  • Type 2 Diabetic Men and Women, aged 30-65
  • BMI 27-40 kg/m2
  • Have been treated with Metformin for at least 8 weeks

Study Procedures:

  • Physical exam
  • Blood and urine collection
  • ECG
  • Oral Glucose Tolerance Test (OGTT)
  • Mixed Meal Tolerance Test (MMTT)
  • Arginine Stimulation Test (AST)
  • Study Medication

Compensation offered? Yes

This study is being conducted under the direction of Dr. Richard Pratley, MD at 301 East Princeton Street, Orlando, Florida 32804.

Study Contact: To learn more, please call 1-877-854-8475 or fill out the Contact us form.